Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Catheter Precision, Inc.: Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
28.08. | Catheter Precision, Inc.: Catheter Precision Announces First Procedures in France as LockeT Expansion Continues | 1 | GlobeNewswire (USA) | ||
CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
21.08. | Catheter Precision, Inc.: Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study | 2 | GlobeNewswire (USA) | ||
18.08. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
18.08. | Catheter Precision's LockeT Wound Closure Device Approved In UK; Shares Soar Over 65% | 1 | RTTNews | ||
15.08. | Catheter Precision executes 1-for-19 reverse stock split | 2 | Seeking Alpha | ||
15.08. | Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split | 320 | GlobeNewswire (Europe) | FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for... ► Artikel lesen | |
15.08. | XFRA 4RM: AUSSETZUNG/SUSPENSION | 383 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCATHETER PR. NEW... ► Artikel lesen | |
15.08. | XFRA NEW INSTRUMENTS AVAILABLE ON 15.08.2025 | 193 | Xetra Newsboard | The following instruments on XETRA do have their first trading 15.08.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 15.08.2025
Aktien
1 US4560361028 Industrial Bank of Korea... ► Artikel lesen | |
14.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 14.08.2025 | 437 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 14.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 14.08.2025.ISIN NameCA87168M1068 SYNEX... ► Artikel lesen | |
14.08. | XFRA ISIN CHANGE | 321 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS74933X6094 Catheter Precision Inc. 14.08.2025 US74933X7084 Catheter Precision Inc. 15.08.2025 Tausch 19:1CA31816R1091 Firefox... ► Artikel lesen | |
14.08. | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.08.2025 | 231 | Xetra Newsboard | Das Instrument PCU US84265V1052 SOUTHERN COPPER DL-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 14.08.2025 und ex Kapitalmassnahme am 15.08.2025 The instrument PCU US84265V1052 SOUTHERN COPPER... ► Artikel lesen | |
13.08. | Catheter Precision, Inc.: First LockeT Cases Completed in Germany | 114 | GlobeNewswire (Europe) | FORT MILL, S.C., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
11.08. | Catheter Precision, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
11.08. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
28.07. | Catheter Precision kündigt Aktienzusammenlegung im Verhältnis 1 zu 19 für August an | 2 | Investing.com Deutsch | ||
28.07. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
30.06. | Catheter Precision, Inc. Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform | 172 | GlobeNewswire (Europe) | FORT MILL, S.C., June 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
26.06. | Catheter Precision, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
12.06. | Catheter Precision, Inc. Comments on Recent Market Activity | 137 | GlobeNewswire (Europe) | FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 46,990 | -0,40 % | Fresenius: Analysten heben Kursziel kräftig an und schüren neue Fantasie für Gesundheitsaktie | Fresenius erhält von der UBS ein deutlich höheres Kursziel, da Analysten dem Gesundheitskonzern neue Wachstumschancen zutrauen. Die Empfehlung zum Kauf bleibt bestehen, während Experten weiteres Aufwärtspotenzial... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 41,730 | +0,05 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
ECKERT & ZIEGLER | 16,550 | -0,24 % | Eckert&Ziegler-Aktie: Kurs mit wenig Bewegung (17,25 €) | An der deutschen Börse ist das Wertpapier von Eckert&Ziegler aktuell unauffällig. Zuletzt zahlten Investoren für das Papier 17,25 Euro. Kaum auffällig ist derzeit am Aktienmarkt der Kurs von Eckert&Ziegler.... ► Artikel lesen | |
BICO GROUP | 2,158 | +5,58 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
SERNOVA BIOTHERAPEUTICS | 0,107 | -0,93 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
CARDINAL HEALTH | 127,85 | -0,27 % | Cardinal Health skizziert auf Konferenz Wachstumspläne und Risiken | ||
RESMED | 236,60 | +0,64 % | Resmed, Inc.: Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority | New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health careSAN DIEGO, Sept. 03, 2025, a global clinical insights initiative dedicated to... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,665 | +0,15 % | RedChip Companies, Inc.: NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 29, 2025 / RedChip Companies will air interviews with NioCorp Developments Ltd. (Nasdaq:NB) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip Small Stocks... ► Artikel lesen | |
UNIDOC HEALTH | 0,136 | -6,71 % | XFRA L7T: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
ZIMMER BIOMET | 90,00 | +0,13 % | ZIMMER BIOMET HOLDINGS, INC. - 8-K, Current Report | ||
SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Aktionäre von Sonoma Pharmaceuticals stimmen allen Anträgen auf der Hauptversammlung zu | ||
CO-DIAGNOSTICS | 0,260 | +1,56 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
VERU | 3,280 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
CYTOSORBENTS | 0,822 | -0,12 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen |